Drug intelligence / Profile preview

albumin human + crystalloid

Development stage
Unknown
Lead developer
Takeda
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Intravenous
01

Overview

Albumin human + crystalloid refers to the combined or sequential administration of human albumin solutions and crystalloid fluids (such as 0.9% sodium chloride or Lactated Ringer's) for volume resuscitation and hemodynamic support. Albumin, a natural colloid derived from human plasma, provides significant oncotic pressure that helps retain fluid within the intravascular compartment, thereby maintaining blood pressure and organ perfusion. Crystalloids are aqueous solutions of mineral salts or other water-soluble molecules that provide immediate fluid resuscitation and maintain extracellular fluid balance. This therapeutic strategy is a cornerstone in the management of critically ill patients, particularly those with severe sepsis, septic shock, or cirrhosis with complications such as spontaneous bacterial peritonitis. Large-scale clinical trials, including the ALBIOS (Albumin Italian Outcome Sepsis) trial and the SAFE (Saline versus Albumin Fluid Evaluation) trial, have investigated the efficacy of adding albumin to standard crystalloid therapy to improve clinical outcomes in these populations.

Other names
albumin plus crystalloidscolloid-crystalloid therapy

Beyond the preview

Go deeper on albumin human + crystalloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albumin human + crystalloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call